Posted on 21 April 2015
Tags: big pharma, Merck, partnering
TetraLogic and Merck will collaborate on a Phase 1 study Read the full story
Posted on 09 April 2015
Tags: big pharma, Merck, partnering
Arvinas announced a strategic collaboration with Merck in which Arvinas’ novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics Read the full story
Posted on 01 April 2015
Tags: big pharma, Merck, partnering
Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat, an investigational epigenetic therapy, with KEYTRUDA Read the full story
Posted on 09 March 2015
Tags: big pharma, Eisai, Merck, partnering
Eisai and Merck announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of Merck’s anti-PD-1 therapy, pembrolizumab Read the full story
Posted on 24 February 2015
Tags: big pharma, Merck, partnering
NGM Biopharmaceuticals and Merck have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas Read the full story
Posted on 14 January 2015
Tags: big pharma, Merck, partnering
Moderna Therapeutics announced a license and collaboration agreement with Merck for the discovery and development of vaccines and passive immunity treatments against viral diseases Read the full story
Posted on 14 January 2015
Tags: big pharma, Eli Lilly, Merck, partnering
Merck and Eli Lilly announced an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical trials Read the full story
Posted on 22 December 2014
Tags: Merck, partnering
Enumeral Biomedical has signed an oncology-focused collaborative study agreement with Merck Read the full story
Posted on 18 December 2014
Tags: big pharma, M&A, Merck
Merck has acquired OncoEthix Read the full story
Posted on 25 November 2014
Tags: big pharma, Merck, partnering, vaccine
Merck and NewLink Genetics have entered into an exclusive worldwide license agreement to research, develop, manufacture, and distribute NewLink's investigational rVSV-EBOV (Ebola) vaccine candidate Read the full story